| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 191.906 | 216.415 | 189.970 | 197.909 | 191.356 | 100.950 | 103.334 | 142.349 | 154.689 | 107.155 |
| Total Income - EUR | 192.043 | 216.417 | 189.970 | 266.697 | 206.695 | 107.804 | 140.295 | 153.936 | 154.689 | 107.155 |
| Total Expenses - EUR | 175.817 | 183.622 | 154.958 | 247.460 | 170.158 | 104.822 | 118.186 | 135.886 | 151.499 | 103.073 |
| Gross Profit/Loss - EUR | 16.226 | 32.795 | 35.012 | 19.237 | 36.537 | 2.981 | 22.109 | 18.050 | 3.190 | 4.082 |
| Net Profit/Loss - EUR | 13.429 | 27.438 | 16.701 | 16.570 | 34.623 | 1.972 | 21.076 | 16.618 | 1.643 | 867 |
| Employees | 11 | 8 | 5 | 1 | 8 | 6 | 6 | 5 | 5 | 4 |
Check the financial reports for the company - Elsimida Com Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 331.364 | 351.135 | 375.587 | 294.162 | 273.800 | 260.799 | 252.352 | 241.620 | 233.160 | 233.822 |
| Current Assets | 42.433 | 40.740 | 32.586 | 26.944 | 38.150 | 28.231 | 67.539 | 60.650 | 54.745 | 52.471 |
| Inventories | 2.795 | 2.956 | 1.686 | 2.095 | 598 | 1.529 | 2.082 | 3.830 | 9.757 | 10.185 |
| Receivables | 31.778 | 29.879 | 25.603 | 23.104 | 35.130 | 19.117 | 54.634 | 53.703 | 37.120 | 33.343 |
| Cash | 7.860 | 7.905 | 5.298 | 1.745 | 2.422 | 7.585 | 10.824 | 3.118 | 7.868 | 8.943 |
| Shareholders Funds | 140.798 | 153.507 | 182.110 | 192.059 | 222.962 | 204.766 | 221.301 | 238.605 | 229.416 | 229.001 |
| Social Capital | 59.055 | 58.453 | 57.464 | 56.409 | 55.317 | 54.268 | 53.065 | 53.229 | 53.068 | 52.771 |
| Debts | 233.000 | 238.369 | 226.064 | 129.047 | 88.988 | 84.264 | 98.582 | 63.665 | 58.489 | 57.292 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5510 - 5510" | |||||||||
| CAEN Financial Year |
5510
|
|||||||||
Comments - Elsimida Com Srl